#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of Pembrolizumab and Enzalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Ireland Poland

  • Study on Apalutamide and Hormone Therapy Before Surgery for Patients with Advanced High-Risk Prostate Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study of Vobramitamab Duocarmazine and Prednisone for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Italy Poland +1

  • Study on the Effect of Degarelix and Ultrasound Therapy for Patients with Intermediate-Risk Prostate Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland

  • Study on Surgery with or without Darolutamide for Patients with High-Risk or Locally Advanced Prostate Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Poland Spain

  • Study of enzalutamide compared to bicalutamide and flutamide in first-line treatment for patients with metastatic prostate cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Ireland

  • Study on the Effectiveness and Safety of Apalutamide and Stereotactic Radiotherapy for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

    Not recruiting

    2 1 1
    Investigated Drugs:
    Slovakia

  • Study on High-Intensity Focused Ultrasound and Leuprorelin Acetate for Intermediate Risk Prostate Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France